Epithalon
L-alanyl-L-glutamyl-L-aspartyl-glycine
Epithalon is a synthetic tetrapeptide consisting of four amino acids (Ala-Glu-Asp-Gly) developed by Khavinson and colleagues in Russia during the late 1980s. With a molecular weight of 390.35 g/mol, this compact peptide mimics a segment of the naturally occurring thymic peptide epithalamin extracted from pineal glands, making it a valuable tool for research into telomere elongation, pineal gland function, and cellular aging processes in controlled experimental settings.
Complete Dosing Guide
Possible Side Effects
Common Side Effects (Rare)
- Mild injection site reactions
- Temporary fatigue
- Slight changes in sleep patterns initially
- Mild headache
Reported Benefits (Not Side Effects)
- Improved sleep quality
- Enhanced energy levels
- Better mood and cognitive function
- Improved skin appearance
Serious Side Effects
- None reported in published studies
- Theoretical concern about telomerase in cancer cells
- Monitor for any unusual symptoms
Medical Disclaimer
Epithalon is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Long-term safety data in humans is extremely limited.